X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (31) 31
oncology (31) 31
index medicus (28) 28
colorectal cancer (19) 19
chemotherapy (16) 16
female (16) 16
identification (16) 16
microbiology (16) 16
cancer therapies (15) 15
male (15) 15
biochemistry (14) 14
chemistry (14) 14
middle aged (14) 14
beer (13) 13
compositions or test papers therefor (13) 13
condition-responsive control in microbiological orenzymological processes (13) 13
enzymology (13) 13
measuring or testing processes involving enzymes, nucleicacids or microorganisms (13) 13
metallurgy (13) 13
metastasis (13) 13
mutation or genetic engineering (13) 13
processes of preparing such compositions (13) 13
spirits (13) 13
vinegar (13) 13
wine (13) 13
aged (12) 12
gene expression (12) 12
genetic aspects (12) 12
medical prognosis (12) 12
cancer (11) 11
compositions thereof (11) 11
culture media (11) 11
immunotherapy (11) 11
microorganisms or enzymes (11) 11
prognosis (11) 11
propagating, preserving or maintaining microorganisms (11) 11
expression (10) 10
research (10) 10
analysis (9) 9
biomarkers (9) 9
hepatocellular carcinoma (9) 9
cell line, tumor (8) 8
colorectal neoplasms - drug therapy (8) 8
genes (8) 8
liver neoplasms - metabolism (8) 8
microarray (8) 8
oligonucleotide microarray (8) 8
original (8) 8
peptides (8) 8
physics (8) 8
studies (8) 8
aged, 80 and over (7) 7
gene-expression (7) 7
health aspects (7) 7
investigating or analysing materials by determining theirchemical or physical properties (7) 7
liver cancer (7) 7
measuring (7) 7
survival (7) 7
testing (7) 7
carcinoma, hepatocellular - genetics (6) 6
carcinoma, hepatocellular - metabolism (6) 6
carcinoma, hepatocellular - pathology (6) 6
colorectal neoplasms - genetics (6) 6
colorectal neoplasms - pathology (6) 6
combination (6) 6
dna microarrays (6) 6
early intrahepatic recurrence (6) 6
gene expression profiling (6) 6
liver neoplasms - pathology (6) 6
lymphocytes (6) 6
metastases (6) 6
multivariate analysis (6) 6
original article (6) 6
original articles (6) 6
peptide vaccine (6) 6
resistance (6) 6
stem cells (6) 6
adult (5) 5
angiogenesis (5) 5
animals (5) 5
antigens (5) 5
apparatus for enzymology or microbiology (5) 5
articles (5) 5
biomarkers, tumor - genetics (5) 5
care and treatment (5) 5
clinical trials (5) 5
colorectal carcinoma (5) 5
colorectal neoplasms - immunology (5) 5
cytotoxicity (5) 5
deoxyribonucleic acid--dna (5) 5
development and progression (5) 5
escherichia coli - genetics (5) 5
gene expression regulation, neoplastic (5) 5
genotype (5) 5
growth (5) 5
kaplan-meier estimate (5) 5
liver neoplasms - genetics (5) 5
micrornas (5) 5
mutation (5) 5
prediction (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cancer Science, ISSN 1347-9032, 03/2017, Volume 108, Issue 3, pp. 455 - 460
Cetuximab has activity against colorectal cancers. Recent studies demonstrated that cetuximab induces antibody‐dependent cell‐mediated cytotoxicity via immune... 
cetuximab | immune‐enhancing effect | colorectal cancer | TILs | Antibody‐dependent cellular cytotoxicity | immune-enhancing effect | Antibody-dependent cellular cytotoxicity | LEUCOVORIN | MULTICENTER PHASE-II | COMBINATION | FLUOROURACIL | PROGNOSTIC VALUE | FOLFIRI | ONCOLOGY | OXALIPLATIN-BASED CHEMOTHERAPY | 1ST-LINE THERAPY | INFLAMMATORY RESPONSE | T-CELLS | Bevacizumab - therapeutic use | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Cetuximab - therapeutic use | Fluorouracil - therapeutic use | Deoxycytidine - therapeutic use | Colorectal Neoplasms - drug therapy | Aged, 80 and over | Adult | Female | Leucovorin - therapeutic use | Liver Neoplasms - pathology | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | CD56 Antigen - metabolism | Camptothecin - therapeutic use | Fluorouracil - analogs & derivatives | Liver Neoplasms - drug therapy | Inflammation - immunology | CD3 Complex - metabolism | CD8 Antigens - metabolism | Colorectal Neoplasms - immunology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Deoxycytidine - analogs & derivatives | Medical research | Immune response | Liver | Colorectal cancer | Antibodies | Metastasis | Antineoplastic agents | Viral antibodies | Antimitotic agents | Chemotherapy | Cell death | Immunotherapy | Medicine, Experimental | Cancer | Peptides | CD8 antigen | Colorectal carcinoma | Cytotoxicity | Cancer therapies | Metastases | Epidermal growth factor | Lymphocytes | CD56 antigen | Lymphoid cells | Immunoglobulins | Research & development--R&D | Invasiveness | CD3 antigen | Inflammation | Immunogenicity | Hepatocytes | Microenvironments | Apoptosis | Original
Journal Article
BMC Cancer, ISSN 1471-2407, 09/2014, Volume 14, Issue 1, pp. 722 - 722
Journal Article
Cancer Science, ISSN 1347-9032, 11/2017, Volume 108, Issue 11, pp. 2229 - 2238
Journal Article
Cancer Science, ISSN 1347-9032, 04/2018, Volume 109, Issue 4, pp. 1101 - 1109
Journal Article
Cancer Science, ISSN 1347-9032, 12/2016, Volume 107, Issue 12, pp. 1825 - 1829
Journal Article
Cancer Science, ISSN 1347-9032, 11/2016, Volume 107, Issue 11, pp. 1599 - 1609
Journal Article
Cancer Science, ISSN 1347-9032, 07/2017, Volume 108, Issue 7, pp. 1504 - 1509
Journal Article
CANCERS, ISSN 2072-6694, 09/2019, Volume 11, Issue 9, p. 1223
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 6_suppl, pp. 625 - 625
625 Background: Although titrated-dose axitinib offers a good objective response rate (ORR) for metastatic renal cell carcinoma (RCC), its optimal initial dose... 
Journal Article